. Paradoxical coronary microcirculatory constriction during ischemia: a synergic function for nitric oxide and endothelin. Am J Physiol Heart Circ Physiol 291: H1814 -H1821, 2006. First published April 28, 2006 doi:10.1152/ajpheart.00220.2006.-A paradoxical microcirculatory constriction has been observed in hearts of patients with ischemia, secondary to coronary stenosis. Here, using the isolated mouse heart (Langendorff), we examined the mechanism of this response, assuming involvement of nitric oxide (NO) and endothelin-1 (ET-1) systems. Perfusion pressure was maintained at 65 mmHg for 70 min (protocol 1), or it was reduced to 30 mmHg over two intervals, between the 20-and 40-min marks (protocol 2) or from the 20-min mark onward (protocol 3). In protocol 1, coronary resistance (CR) remained steady in untreated heart, whereas it progressively increased during treatment with the NO synthesis inhibitor N G -nitro-L-arginine methyl ester (L-NAME) (2.7-fold) or the ETA antagonist BQ-610 (2.8 fold). The ETB antagonist BQ-788 had instead no effect by itself but curtailed vasoconstriction to BQ-610. In protocol 2, hypotension raised CR by 2.2-fold. This response was blunted by reactive oxygen species (ROS) scavengers (mannitol and superoxide dismutase plus catalase) and was converted into vasodilation by L-NAME, BQ-610, or BQ-788. Restoration of normal pressure was followed by vasodilation and vasoconstriction, respectively, in untreated and treated preparations. In protocol 3, CR progressively increased with hypotension in the absence but not presence of L-NAME or BQ-610. We conclude that the coronary vasculature is normally relaxed by two concerted processes, a direct action of NO and ET-1 curtailing an ETB2-mediated tonic vasoconstriction through ETA activation. The negative feedback mechanism on ETB2 subsides during hypotension, and the ensuing vasoconstriction is ascribed to ET-1 activating ETA and ETB2 and reactive nitrogen oxide species originating from ROS-NO interaction. coronary circulation; reactive oxygen species; vasomotor tone CORONARY AUTOREGULATION REFLECTS the intrinsic capability of coronary microvessels to dilate in response to a reduction in pressure so as to maintain a flow constant within certain limits (7). Below this autoregulatory break point, flow decreases and becomes pressure dependent, while vasodilation is maximal (4). However, this conventional model of coronary blood flow control has been challenged by studies (24,30,32,34) in patients presenting severe microcirculatory vasoconstriction rather than vasodilation during spontaneous or demand-induced ischemia. Because of the concomitant coronary artery disease, it has been hypothesized that this paradoxical response results from reduced nitric oxide (NO) bioavailability (20,25) and/or increased endothelin (ET) release (20), because both such events are characteristic of coronary atherosclerosis. However, microcirculatory vasoconstriction, or submaximal vasodilation, has also been observed in the normal animal during severe ischemia or cor...